American Health Packaging Recall: GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (
American Health Packaging Recall: GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets ( is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: American Health Packaging; Product: GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American
| Recalling firm | American Health Packaging |
|---|---|
| Product | GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21 |
| Reason for recall | Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide in the USA |
| Recall initiated | 20190408 |
| Recall number | D-1276-2019 |
| Category | drug |
| State | OH |
| Country | United States |
$29/mo
Try RecallGuard →